文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

采用离子凝胶技术制备单分散、低分子量壳聚糖纳米粒子的形成机制。

Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.

机构信息

School of Life Science, Hubei University, Wuhan, China.

出版信息

Colloids Surf B Biointerfaces. 2012 Feb 1;90:21-7. doi: 10.1016/j.colsurfb.2011.09.042. Epub 2011 Oct 2.


DOI:10.1016/j.colsurfb.2011.09.042
PMID:22014934
Abstract

Chitosan nanoparticles have been extensively studied for drug and gene delivery. In this paper, monodisperse, low molecular weight (LMW) chitosan nanoparticles were prepared by a novel method based on ionic gelation using sodium tripolyphosphate (TPP) as cross-linking agent. The objective of this study was to solve the problem of preparation of chitosan/TPP nanoparticles with high degree of monodispersity and stability, and investigate the effect of various parameters on the formation of LMW chitosan/TPP nanoparticles. It was found that the particle size distribution of the nanoparticles could be significantly narrowed by a combination of decreasing the concentration of acetic acid and reducing the ambient temperature during cross-linking process. The optimized nanoparticles exhibited a mean hydrodynamic diameter of 138 nm with a polydispersity index (PDI) of 0.026 and a zeta potential of +35 mV, the nanoparticles had good storage stability at room temperature up to at least 20 days.

摘要

壳聚糖纳米粒已被广泛研究用于药物和基因传递。在本文中,通过一种基于离子凝胶化的新方法,使用三聚磷酸钠(TPP)作为交联剂,制备了单分散的低分子量(LMW)壳聚糖纳米粒。本研究的目的是解决壳聚糖/TPP 纳米粒制备中具有高单分散性和稳定性的问题,并研究各种参数对 LMW 壳聚糖/TPP 纳米粒形成的影响。结果发现,通过降低乙酸浓度和降低交联过程中的环境温度的组合,可以显著缩小纳米粒的粒径分布。优化的纳米粒具有 138nm 的平均水动力直径,多分散指数(PDI)为 0.026,zeta 电位为+35mV,纳米粒在室温下具有良好的储存稳定性,至少可稳定 20 天。

相似文献

[1]
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.

Colloids Surf B Biointerfaces. 2011-10-2

[2]
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.

Colloids Surf B Biointerfaces. 2005-8

[3]
Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate.

Mol Pharm. 2012-9-4

[4]
Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.

Crit Rev Ther Drug Carrier Syst. 2016

[5]
Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.

Int J Pharm. 2007-5-4

[6]
Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.

Int J Pharm. 2010-4-1

[7]
Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.

Colloids Surf B Biointerfaces. 2011-10-12

[8]
Development and characterisation of chitosan nanoparticles for siRNA delivery.

J Control Release. 2006-10-10

[9]
Synthesis of chitosan-stabilized gold nanoparticles in the absence/presence of tripolyphosphate.

Biomacromolecules. 2004

[10]
Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.

Drug Dev Ind Pharm. 2009-6

引用本文的文献

[1]
Advancements in Chitosan and Cellulose Nanoparticles for Stem Cell-Based Tissue Engineering.

Stem Cell Rev Rep. 2025-9-4

[2]
Development and Characterization of LL37 Antimicrobial-Peptide-Loaded Chitosan Nanoparticles: An Antimicrobial Sustained Release System.

Polymers (Basel). 2025-7-7

[3]
Preparation and Anti-cancer Evaluation of Methotrexate-loaded Inositol-6 Phosphate Cross-linked Chitosan Nanoparticles on Breast Cancer.

Adv Pharm Bull. 2025-3-8

[4]
Syringic acid loaded chitosan nanoparticles mitigate glycation associated oxidative stress and inflammation in hyperglycaemic rat model.

Sci Rep. 2025-7-2

[5]
Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy.

Pharmaceutics. 2025-5-22

[6]
Chitosan Nanoparticles: Approaches to Preparation, Key Properties, Drug Delivery Systems, and Developments in Therapeutic Efficacy.

AAPS PharmSciTech. 2025-4-17

[7]
Folic Acid-Conjugated Magnetic Oleoyl-Chitosan Nanoparticles for Controlled Release of Doxorubicin in Cancer Therapy.

Nanomaterials (Basel). 2025-3-7

[8]
Nigella sativa monophosphoryl lipid A nanoliposome: a promising antibiotic alternative and immunomodulator to control virulent pandemic drug-resistant Salmonella pullorum infection in broiler chicks.

BMC Vet Res. 2025-3-3

[9]
Uptake and Inhibition of P-Glycoprotein-Mediated Efflux Evaluation of Encapsulated Methotrexate Chitosan and Hypromellose Phthalate Nanoparticles for Potential Glioblastoma Treatment.

Pharmaceutics. 2025-2-12

[10]
Effect of Surface Properties of Chitosan-Based Nanoparticles in the Skin-Diffusion Rate.

Biopolymers. 2025-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索